Evidence map›Paper›PMID 23524851›Full record

ArticleThe EMBO journal2013

SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia.

Chun Guo, Keri L Hildick, Jia Luo, Laura Dearden, Kevin A Wilkinson, Jeremy M Henley

Abstract read
In one paragraph

Article in The EMBO journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 211 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. DRP1, fission and apoptosis.Cell death discovery · 2025
    Review
  17. Review
  18. Review
  19. Article
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chun GuoSchool of Biochemistry, University of Bristol, University Walk, Bristol BS8 1TD, UK.
Keri L Hildick
Jia Luo
Laura Dearden
Kevin A Wilkinson
Jeremy M Henley
University of Bristol · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K014358/1Medical Research CouncilWellcome Trust
6 · The paper itself

Abstract

Global increases in small ubiquitin-like modifier (SUMO)-2/3 conjugation are a neuroprotective response to severe stress but the mechanisms and specific target proteins that determine cell survival have not been identified. Here, we demonstrate that the SUMO-2/3-specific protease SENP3 is degraded during oxygen/glucose deprivation (OGD), an in vitro model of ischaemia, via a pathway involving the unfolded protein response (UPR) kinase PERK and the lysosomal enzyme cathepsin B. A key target for SENP3-mediated deSUMOylation is the GTPase Drp1, which plays a major role in regulating mitochondrial fission. We show that depletion of SENP3 prolongs Drp1 SUMOylation, which suppresses Drp1-mediated cytochrome c release and caspase-mediated cell death. SENP3 levels recover following reoxygenation after OGD allowing deSUMOylation of Drp1, which facilitates Drp1 localization at mitochondria and promotes fragmentation and cytochrome c release. RNAi knockdown of SENP3 protects cells from reoxygenation-induced cell death via a mechanism that requires Drp1 SUMOylation. Thus, we identify a novel adaptive pathway to extreme cell stress in which dynamic changes in SENP3 stability and regulation of Drp1 SUMOylation are crucial determinants of cell fate.

Indexed as

SumoylationAnimalsApoptosisCell DeathCell LineCysteine EndopeptidasesCytochromes cCytosolDynaminseIF-2 KinaseEmbryo, MammalianGene Expression RegulationGlucoseGTP PhosphohydrolasesHumansIschemiaCysteine EndopeptidasesCytochromes cDNM1L protein, humanDynaminsEIF2AK3 protein, humaneIF-2 KinaseGlucoseGTP PhosphohydrolasesMicrotubule-Associated ProteinsMitochondrial ProteinsOxygenSENP3 protein, humanSmall Ubiquitin-Related Modifier Proteins

Identifiers

PMID23524851
PMCPMC3671254
OpenAlexW2032328307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.